Swiss National Bank Sells 4,200 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Swiss National Bank reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 583,100 shares of the company’s stock after selling 4,200 shares during the period. Swiss National Bank owned about 0.23% of HCA Healthcare worth $236,989,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Atlanta Consulting Group Advisors LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $311,000. Natixis Advisors LLC grew its stake in shares of HCA Healthcare by 2.3% in the third quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock worth $44,750,000 after purchasing an additional 2,459 shares during the last quarter. Mizuho Securities USA LLC lifted its holdings in HCA Healthcare by 205.4% during the 3rd quarter. Mizuho Securities USA LLC now owns 45,637 shares of the company’s stock worth $18,548,000 after buying an additional 30,693 shares during the period. Simplify Asset Management Inc. increased its stake in shares of HCA Healthcare by 67.1% in the third quarter. Simplify Asset Management Inc. now owns 2,351 shares of the company’s stock valued at $956,000 after buying an additional 944 shares during the period. Finally, Valley Wealth Managers Inc. increased its position in HCA Healthcare by 14.4% during the 3rd quarter. Valley Wealth Managers Inc. now owns 1,383 shares of the company’s stock valued at $562,000 after purchasing an additional 174 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 0.7 %

NYSE HCA opened at $342.96 on Monday. HCA Healthcare, Inc. has a 12 month low of $238.82 and a 12 month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $86.87 billion, a P/E ratio of 15.40, a PEG ratio of 1.32 and a beta of 1.68. The business has a fifty day simple moving average of $385.11 and a 200 day simple moving average of $357.92.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. Barclays decreased their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Wells Fargo & Company boosted their price target on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Finally, Morgan Stanley initiated coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $385.00.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,155 shares of company stock worth $5,608,990. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.